Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01244750 · ClinicalTrials.gov registry record
Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
A clinical trial, sponsored by Bristol-Myers Squibb.
- Completed
- Registry status
- 1,494
- Enrollment target
NCT01244750 is a clinical trial that has completed, run by Bristol-Myers Squibb. The registered enrollment target is 1,494 participants.
The verdict
NCT01244750 has completed, sponsored by Bristol-Myers Squibb.
- COMPLETED
- Registry status
- 1,494 participants
- Enrollment target
Study Summary
The purpose of this study is to better understand the use of tyrosine kinase inhibitors (TKI) in patients newly diagnosed with CML and their quality of life in a real-world setting.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,494 participants |
| Start Date | 2010-12-02 |
| Est. Completion | 2020-01-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01244750
The ClinicalTrials.gov registry entry for NCT01244750 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,494 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01244750 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01244750 about?
NCT01244750 is a clinical study titled "Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting". The purpose of this study is to better understand the use of tyrosine kinase inhibitors (TKI) in patients newly diagnosed with CML and their quality of life in a real-world setting.
What is the current status of trial NCT01244750?
This trial is currently completed. The enrollment target is 1,494 participants. The study started on 2010-12-02. Estimated completion is 2020-01-08.
Who is sponsoring clinical trial NCT01244750?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.